Renya Zeng

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “The Hippo Signaling Pathway in Drug Resistance in Cancer”.

The Hippo Signaling Pathway in Drug Resistance in Cancer

Cancers(2021)10.3390/cancers13020318

N/A

0DataRank · unranked

87 citations

Jixin Dong, Renya Zeng

Protein kinase RNA-activated controls mitotic progression and determines paclitaxel chemosensitivity through B-cell lymphoma 2 in ovarian cancer

Oncogene(2021)10.1038/s41388-021-02117-5

N/A

0DataRank · unranked

18 citations

Yongji Zeng, Renya Zeng, Yuanhong Chen, Tian‐Li Wang, Kerry J. Rodabaugh +5 more

MARK2 regulates chemotherapeutic responses through class IIa HDAC-YAP axis in pancreatic cancer

Oncogene(2022)10.1038/s41388-022-02399-3

N/A

0DataRank · unranked

20 citations

Ling Yin, Jiuli Zhou, Renya Zeng, Yi Xiao, Adrian R. Black +8 more

FGFR4 inhibition augments paclitaxel-induced cell death in ovarian cancer

International Immunopharmacology(2025)10.1016/j.intimp.2025.114626

N/A

0DataRank · unranked

1 citations

Xingcheng Chen, Yuanhong Chen, Jixin Dong, Renya Zeng